FDA taps prior knowledge to expedite cell and gene therapy development

BioSpace

A year of significant policy change at the FDA brought momentum and scrutiny into the new year.

pharminent June 3, 2026 (Last updated: June 3, 2026)

BioSpace

A year of significant policy change at the FDA brought momentum and scrutiny into the new year.

Related Stories